Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06136377
What this trial is testing

Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.

Who this might be right for
Patients With Metastatic Castration-resistant Prostate Cancer
Centre Georges Francois Leclerc 35
Early research (Phase 1)Looking for participantsNCT07096128
What this trial is testing

[177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer

Who this might be right for
mCRPC
Jinming Zhang 36
Testing effectiveness (Phase 2)Study completedNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Early research (Phase 1)Ended earlyNCT07500987
What this trial is testing

Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC

Who this might be right for
EGFR Mutation-positive NSCLC
AstraZeneca 6
Early research (Phase 1)Ended earlyNCT00975299
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Bayer 16
Not applicableStudy completedNCT03783325
What this trial is testing

Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma

Who this might be right for
Nevi and Melanomas
University of Colorado, Denver 71
Early research (Phase 1)Study completedNCT00407693
What this trial is testing

PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28

Who this might be right for
Healthy
National Institute of Mental Health (NIMH) 51
Very early researchStudy completedNCT04897763
What this trial is testing

Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC

Who this might be right for
Bladder Cancer
Institut Cancerologie de l'Ouest 6
Testing effectiveness (Phase 2)UnknownNCT06081686
What this trial is testing

Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sinotau Pharmaceutical Group 32
Not applicableStudy completedNCT00314470
What this trial is testing

Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute

Who this might be right for
Healthy
AHS Cancer Control Alberta 40
Very early researchNot Yet RecruitingNCT07381582
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
Peking Union Medical College Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02880007
What this trial is testing

Dose Optimization in 3D Pulsed Dose Rate Brachytherapy for Patients With Locally Advanced Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaStage IB Cervical CancerStage II Cervical Cancer+1 more
Institut de Cancérologie de Lorraine 48
Not applicableUnknownNCT06581744
What this trial is testing

Non Invasive Imaging Methods for Detecting PA：a Clinical PET Study of 18F-Pentixather

Who this might be right for
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Fangfang Sun 20
Early research (Phase 1)Study completedNCT01359852
What this trial is testing

[11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult Volunteers

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20
Early research (Phase 1)Ended earlyNCT05432193
What this trial is testing

FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerEsophageal Cancer+4 more
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company 20
Early research (Phase 1)Study completedNCT01153607
What this trial is testing

Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 24
Not applicableStudy completedNCT00643617
What this trial is testing

CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry

Who this might be right for
Prostate CancerProstatic CancerProstatic Neoplasms+2 more
Accuray Incorporated 307
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711135
What this trial is testing

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

Who this might be right for
Gastroenteropancreatic Neuroendocrine TumorsPheochromocytomaParaganglioma
Advanced Accelerator Applications 11
Early research (Phase 1)Ended earlyNCT02053324
What this trial is testing

AvidinOX + [177Lu]DOTA-biotin (or 177Lu-ST2210) Complex in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Liver Metastases
Alfasigma S.p.A. 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05896371
What this trial is testing

Personalized PSMA Radiopharmaceutical Therapy

Who this might be right for
CancerProstate CancerMetastatic Cancer+1 more
CHU de Quebec-Universite Laval 500
Next Page